Identification and characterization of benzo[d]oxazol-2(3H)-one derivatives as the first potent and selective small-molecule inhibitors of chromodomain protein CDYL
- 1 November 2019
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 182, 111656
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31871083, 81371432, 21572010, 21772005)
This publication has 45 references indexed in Scilit:
- Potent inhibition of DOT1L as treatment of MLL-fusion leukemiaBlood, 2013
- Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2Proceedings of the National Academy of Sciences of the United States of America, 2013
- Epigenetic protein families: a new frontier for drug discoveryNature Reviews Drug Discovery, 2012
- Corepressor Protein CDYL Functions as a Molecular Bridge between Polycomb Repressor Complex 2 and Repressive Chromatin Mark Trimethylated Histone Lysine 27Journal of Biological Chemistry, 2011
- Selective Inhibitors of Histone Methyltransferase DOT1L: Design, Synthesis, and Crystallographic StudiesJournal of the American Chemical Society, 2011
- Interaction Proteomics Analysis of Polycomb Proteins Defines Distinct PRC1 Complexes in Mammalian CellsMolecular & Cellular Proteomics, 2011
- Epigenetic modifications as therapeutic targetsNature Biotechnology, 2010
- Multimerization and H3K9me3 Binding Are Required for CDYL1b Heterochromatin AssociationJournal of Biological Chemistry, 2009
- Specificity of the Chromodomain Y Chromosome Family of Chromodomains for Lysine-methylated ARK(S/T) MotifsJournal of Biological Chemistry, 2008
- The language of covalent histone modificationsNature, 2000